Samuel Bates Martin - Net Worth and Insider Trading
Samuel Bates Martin Net Worth
The estimated net worth of Samuel Bates Martin is at least $900,036 dollars as of 2024-05-27. Samuel Bates Martin is the SVP AND CFO of Celldex Therapeutics Inc and owns about 24,378 shares of Celldex Therapeutics Inc (CLDX) stock worth over $900,036. Details can be seen in Samuel Bates Martin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Samuel Bates Martin has not made any transactions after 2022-08-12 and currently still holds the listed stock(s).
Transaction Summary of Samuel Bates Martin
Samuel Bates Martin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Samuel Bates Martin owns 1 companies in total, including Celldex Therapeutics Inc (CLDX) .
Click here to see the complete history of Samuel Bates Martin’s form 4 insider trades.
Insider Ownership Summary of Samuel Bates Martin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2022-08-12 | SVP and CFO |
Samuel Bates Martin Latest Holdings Summary
Samuel Bates Martin currently owns a total of 1 stock. Samuel Bates Martin owns 24,378 shares of Celldex Therapeutics Inc (CLDX) as of August 12, 2022, with a value of $900,036.
Latest Holdings of Samuel Bates Martin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2022-08-12 | 24,378 | 36.92 | 900,036 |
Holding Weightings of Samuel Bates Martin
Samuel Bates Martin Form 4 Trading Tracker
According to the SEC Form 4 filings, Samuel Bates Martin has made a total of 5 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Celldex Therapeutics Inc is the sale of 20,000 shares on August 12, 2022, which brought Samuel Bates Martin around $730,400.
Insider Trading History of Samuel Bates Martin
- 1
Samuel Bates Martin Trading Performance
GuruFocus tracks the stock performance after each of Samuel Bates Martin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Samuel Bates Martin is 301%. GuruFocus also compares Samuel Bates Martin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Samuel Bates Martin within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Samuel Bates Martin's insider trading performs compared to the benchmark.
Performance of Samuel Bates Martin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 315.05 | | | | | |
| Relative Return to S&P 500(%) | 316.77 | | | | | |
Samuel Bates Martin Ownership Network
Samuel Bates Martin Owned Company Details
What does Celldex Therapeutics Inc do?
Who are the key executives at Celldex Therapeutics Inc?
Samuel Bates Martin is the SVP and CFO of Celldex Therapeutics Inc. Other key executives at Celldex Therapeutics Inc include Sen. VP & Ch Scientific Off. Tibor Keler , SVP of Corp. Affairs & Admin. Sarah Cavanaugh , and SVP & Chief Medical Officer Diane C. Young .
Celldex Therapeutics Inc (CLDX) Insider Trades Summary
Over the past 18 months, Samuel Bates Martin made no insider transaction in Celldex Therapeutics Inc (CLDX). Other recent insider transactions involving Celldex Therapeutics Inc (CLDX) include a net sale of 16,860 shares made by Tibor Keler ,
In summary, during the past 3 months, insiders sold 0 shares of Celldex Therapeutics Inc (CLDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,860 shares of Celldex Therapeutics Inc (CLDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 16,860 shares.
Celldex Therapeutics Inc (CLDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Celldex Therapeutics Inc Insider Transactions
Samuel Bates Martin Mailing Address
Above is the net worth, insider trading, and ownership report for Samuel Bates Martin. You might contact Samuel Bates Martin via mailing address: C/o Celldex Therapeutics, Inc., 53 Frontage Road, Suite 220, Hampton Nj 08827.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
